PATENT CLAIM ANALYSIS

Application Number: 16202487
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-04
Patent Classification: ["514", "759000"]

Abstract:
The present invention relates to a polymorph of a compound of formula (I) This polymorph is particularly suitable in treating IPF by pulmonary administration.

Claim (Index 2):
The polymorph of  claim 1 , wherein the polymorph is a hydrate.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 98.0
- Lexical Diversity: 1.125
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16062206', '15323967', '14438977', '14966427', '13832672']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7641972804286645
- 35 USC 102 Novelty (BERT): 0.5862975126459941
- Combined Prediction Score: 0.7464073036503975
- Mean Citation Score: 303.12529
- Max Citation Score: 551.9757
- Similarity Product: 390.3813258651496

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test